Award Year / Program / Phase:1985 / SBIR / Phase I
Agency:HHS
Principal Investigator:Frank waxman , PRINCIPAL INVESTIGATOR
Award Amount:$49,740.00
Abstract:
The goal of this project is to develop a commercial product with the capacity to enhance erythrocyte cr1 receptors. additional information is considered proprietary.